In Vivo · Published 2026-06-30 · DOI 10.21873/invivo.14380
NOBUKI FURUBAYASHI, TAKEHITO KOJIMA, YASUHIRO NAKANO, AKARI KATAOKA, MOTONOBU NAKAMURA, TAKAHITO NEGISHI
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
FURUBAYASHI, N., KOJIMA, T., NAKANO, Y., et al. (2026). Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery. In Vivo. https://doi.org/10.21873/invivo.14380